首页
当前位置：
首页 > 免疫性角膜病 > 免疫性角膜病：参考文献(眼科学 免疫性角膜病)

免疫性角膜病：参考文献(眼科学 免疫性角膜病)

免疫性角膜病, 眼科学, 眼角膜疾病图解 02-11 463 0
导语：免疫性角膜病：参考文献属于眼科学下的免疫性角膜病分支内容。本篇围绕眼科学 免疫性角膜病：参考文献主题，主要讲述眼角膜疾病参考文献等方面医学知识。
  • 1. Giese MJ，Adamu SA，Pitchekian-Halabi H，et al. The effect of Staphylococcus aureus phage lysate vaccine on a rabbit model of staphylococcal blepharitis，phlyctenulosis，and catarrhal infiltrates. Am J Ophthalmol，1996，122：245-254.
  • 2. Schwartz GS，Harrison AR，Holland EJ. Etiology of immune stromal （interstitial） keratitis. Cornea，1998，17：278-281.
  • 3. Holland EJ，Schwartz GS. Classification of herpes simplex virus keatitis. Cornea，1999，18：144-154.
  • 4. 谢立信. 角膜移植学 . 北京：人民卫生出版社，2000.
  • 5. Wall V，Yen MT，Yang MC，et al. Management of the late ocular sequelae of Stevens-Johnson syndrome. Ocul Surf，2003，1：192-201.
  • 6. Watson，SL，Hollingsworth，J，Tullo，AB. Confocal microscopy of Thygeson’s superficial punctate keratopathy. Cornea，2003，22 ：294-299.
  • 7. Tabery HM. Filamentary keratopathy：a non-contact photomicrographic in vivo study in the human cornea. Eur J Ophthalmol，2003，13：599-605.
  • 8. Orsoni JG，Zavota L，Manzotti F，et al. Syphilitic interstitial keratitis：treatment with immunosuppressive drug combination therapy，Cornea，2004，23：530-532.
  • 9. Nagra PK，Rapuano CJ，Cohen EJ，et al. Thygeson’s superficial punctate keratitis - Ten years’experience. Opthalmology，2004，111：34-37.
  • 10. Ono SJ，Abelson MB. Allergic conjunctivitis：Update on pathophysiology and prospects for future treatment . J Allergy Clin Immun，2005，115：118-122.
  • 11. Tatlipinar S，Akpek EK. Topical ciclosporin in the treatment of ocular surface disorders. Br J Opthalmol，2005，89：1363-1367.
  • 12. Wilhelmus KR，Jones DB. Adult-onset syphilitic stromal keratitis. Am J Ophthalmol. 2006，141：319-321.
  • 13. Kafkala C，Choi J，Zafirakis P，et al. Mooren ulcer：an immunopathologic study. Cornea，2006，25：667-673.
  • 14. Kumagai N，Fukuda K ，Fujitsu Y，et al. Role of structural cells of the cornea and conjunctiva in the pathogenesis of vernal keratoconjunctivitis. Prog Retin Eye Res，2006，25：165-187.
  • 15. Daniell M，Constantinou M，Vu HT，et al. Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis. Br J Opthalmol，2006，90 ：461-464.
  • 16. Fukushima A，Yamaguchi T，Ishida W，et al. Cyclosporin A inhibits eosinophilic infiltration into the conjunctiva mediated by type IV allergic reactions. Clin Exp Opthalmol，2006，34 ：347-353.
  • 17. Connell PP，O'Reilly J，Coughlan S，et al The role of common viral ocular pathogens in Thygeson’s superficial punctate keratitis. Br J Opthalmol，2007，91：1038-1041.
  • 18. Duszak，Robert S. Diagnosis and management of Thygeson’s superficial punctate keratitis. Optometry，2007，78：333-338.
  • 19. 谢立信，史伟云. 角膜病学 . 北京：人民卫生出版社，2007.
  • 20. 李莹，译，谢立信，审. 角膜理论基础与临床实践. 天津：天津科技翻译出版社，20007.
  • 21. De Rojas MV，Dart JK，Saw VP. The natural history of Stevens Johnson syndrome：patterns of chronic ocular disease and the role of systemic immunosuppressive therapy. Br J Ophthalmol，2007，91：1048-1053.
  • 22. Mantelli F，Santos MS，Petitti T，et al. Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitis. Br J Opthalmol，2007，97：1656-1661.
  • 23. Dogru M，Kato N，Matsumoto Y，et al. Immunohistochemistry and electron microscopy of retrocorneal scrolls in syphilitic interstitial keratitis. Curr Eye Res，2007，32：863-870.
  • 24. Yip LW，Thong BY，Lim J，et al. Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis：an Asian series. Allergy，2007，62：527-531.
  • 25. Diebold Y，Chen LL，Tepavcevic V，Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas （lpr） mouse model of Sjögren’s syndrome. Exp Eye Res，2007，84：500-512.
  • 26. Hyon JY，Lee YJ，Yun PY. Management of ocular surface inflammation in Sjögren syndrome. Cornea，2007，26：S13-15.
  • 27. Shen YC，Wang CY，Chen YC，et al. Progressive herpetic linear endotheliitis. Cornea，2007，26：365-367.
  • 28. Kocabeyoglu S，Bozkurt B，Bilen O，et al. Serum allergen specific immunoglobulin E levels in patients with allergic conjunctivitis. Eur J Opthalmoll，2008， 18：675-679.
  • 29. Tandon R，Chawla B，Verma K，et al. Outcome of treatment of mooren ulcer with topical cyclosporine a 2%. Cornea，2008，27（8）：859-861.
  • 30. Koizumi N，Suzuki T，Uno T，et al. Cytomegalovirus as an etiologic factor in corneal endotheliitis. Ophthalmology，2008，115：292-297.
  • 31. Ueta M，Tokunaga K，Sotozono C，et al. HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese. Mol Vis，2008，17：550-555.
  • 32. Liu C，Okera S，Tandon R，et al. Visual rehabilitation in end-stage inflammatory ocular surface disease with the osteo-odonto-keratoprosthesis：results from the UK. Br J Ophthalmol，2008，92：1211-1217.
  • 33. Kawamoto K，Chikama T，Takahashi N，et al. In vivo observation of Langerhans cells by laser confocal microscopy in Thygeson’s superficial punctate keratitis. Mol Vis，2009，15：1456-1462.
  • 34. Fukuda K，Ohbayashi M，Morohoshi K，et al. Critical role of IgE-dependent mast cell activation in a murine model of allergic conjunctivitis. J Allergy Clin Immun，2009，124：827-833.
  • 35. Burmy S，Patel H，Rutner D. Adolescent interstitial keratitis secondary to intrauterine TB exposure. Optometry，2009，80：307.
  • 36. Gueudry J，Roujeau JC，Binaghi M，et al. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol，2009，145：157-162.
  • 37. Hwang YS，Hsiao CH，Tan HY，et al. Corneal endotheliitis. Ophthalmology，2009，116：164-164.
  • 38. Sotozono C，Ueta M，Koizumi N，et al. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications. Ophthalmology，2009，116：685-690.
  • 39. Araki Y，Sotozono C，Inatomi T，et al. Successful treatment of Stevens-Johnson syndrome with steroid pulse therapy at disease onset. Am J Ophthalmol，2009，147：1004-1011.
  • 40. Phillips EJ，Mallal SA. HLA and drug-induced toxicity. Curr Opin Mol Ther. 2009 ，11：231-242.
  • 41. Nguyen CQ，Peck AB. Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease. Ocul Surf，2009，7：11-27.
  • 42. Wetter DA，Camilleri MJ. Clinical，etiologic，and histopathologic features of Stevens-Johnson syndrome during an 8-year period at Mayo Clinic. Mayo Clin Proc，2010，85（2）：131-138.
  • 43. Kumar Sunil，Gupta N，Vivian AJ. Modern approach to managing vernal keratoconjunctivitis. Curr Allergy Asthma Rep，2010，10：155-162.
  • 44. Gelardi M，Spadavecchia L，Fanelli P，et al. Nasal inflammation in vernal keratoconjunctivitis. J Allergy Clin Immun，2010，125：496-498.
  • 45. Sacchetti M，Lambiase A，Mantelli F，et al. Tailored Approach to the Treatment of Vernal Keratoconjunctivitis. Opthalmology，2010，117：1294-1299.
  • 46. Kim SH，Ye YM，Palikhe NS，et al. Genetic and ethnic risk factors associated with drug hypersensitivity. Curr Opin Allergy Clin Immunol，2010，10：280-290.
  • 47. Akpek EK，Klimava A，Thorne JE，et al. Evaluation of patients with dry eye for presence of underlying Sjögren syndrome.Cornea，2009，28：493-497.
标签：